12-121222967-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002560.3(P2RX4):c.448G>A(p.Val150Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000561 in 1,613,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002560.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000420 AC: 64AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000335 AC: 84AN: 250386Hom.: 0 AF XY: 0.000369 AC XY: 50AN XY: 135472
GnomAD4 exome AF: 0.000576 AC: 841AN: 1460796Hom.: 0 Cov.: 29 AF XY: 0.000548 AC XY: 398AN XY: 726756
GnomAD4 genome AF: 0.000420 AC: 64AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.448G>A (p.V150I) alteration is located in exon 5 (coding exon 5) of the P2RX4 gene. This alteration results from a G to A substitution at nucleotide position 448, causing the valine (V) at amino acid position 150 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at